Get the Stockscreener App
1.17
4.10%
-0.05
Sellas Life Sciences Group Inc stock is traded at $1.17, with a volume of 967.35K.
It is down -4.10% in the last 24 hours and up +0.86% over the past month.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
See More
Previous Close:
$1.22
Open:
$1.21
24h Volume:
967.35K
Relative Volume:
1.63
Market Cap:
$83.40M
Revenue:
-
Net Income/Loss:
$-37.34M
P/E Ratio:
-0.7548
EPS:
-1.55
Net Cash Flow:
$-36.91M
1W Performance:
-11.36%
1M Performance:
+0.86%
6M Performance:
-18.18%
1Y Performance:
+15.84%
1-Day Range:
$1.16
$1.23
1-Week Range:
$1.16
$1.38
52-Week Range:
$0.4986
$1.72
Sellas Life Sciences Group Inc Stock (SLS) Company Profile
Name
Sellas Life Sciences Group Inc
Sector
Industry
Phone
(646) 200-5278
Address
7 TIMES SQUARE, NEW YORK, NY
Compare SLS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| SLS | 1.17 | 83.40M | 0 | -37.34M | -36.91M | -1.55 |
| VRTX | 450.97 | 116.38B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 738.00 | 82.09B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 605.92 | 36.14B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 244.89 | 31.59B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 113.13 | 27.25B | 3.30B | -501.07M | 1.03B | 11.54 |
Sellas Life Sciences Group Inc Stock (SLS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-21-21 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-01-18 | Initiated | Oppenheimer | Outperform |
| Apr-02-18 | Initiated | H.C. Wainwright | Buy |
| Mar-19-18 | Upgrade | Maxim Group | Hold → Buy |
Sellas Life Sciences Group Inc Stock (SLS) Latest News
We're A Little Worried About SELLAS Life Sciences Group's (NASDAQ:SLS) Cash Burn Rate - Yahoo Finance
SELLAS Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Update - The Manila Times
SELLAS Reports 31% Response Rate in AML Trial, Narrows Q3 Loss to $7.1M | SLS Stock News - StockTitan
Highbridge Capital Management's Strategic Acquisition of SELLAS Life Sciences Shares - GuruFocus.com
SELLAS Life Sciences to Present at the 66th American Society of Hematology (ASH) Annual Meeting & Exposition 2024 - GlobeNewswire
Northrop Grumman Corp (NOC-N) QuotePress Release - The Globe and Mail
SELLAS' Cancer Drug Shows 50% Response Rate in Leukemia Trial, Doubles Survival Time | SLS Stock News - StockTitan
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) Sees Large Decrease in Short Interest - MarketBeat
FDA grants rare pediatric disease designation to SELLAS cancer drug By Investing.com - Investing.com Australia
SELLAS Announces U.S. FDA Rare Pediatric Disease - GlobeNewswire
SELLAS Announces U.S. FDA Rare Pediatric Disease Designation (RPDD) Granted to Galinpepimut-S - The Bakersfield Californian
SELLAS Announces U.S. FDA Rare Pediatric Disease Designation (RPDD) Granted to Galinpepimut-S (GPS) for the Treatment of Pediatric Acute Myeloid Leukemia - StockTitan
SELLAS Life Sciences to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit - GlobeNewswire
Trading Day Triumph: SELLAS Life Sciences Group Inc (SLS) Ends at 1.19, a -2.46 Surge/Plunge - The Dwinnex
Nvidia Corp (NVDA-Q) QuotePress Release - The Globe and Mail
SELLAS extends Times Square lease through 2026 - Investing.com
SELLAS extends Times Square lease through 2026 By Investing.com - Investing.com Australia
What is SELLAS Life Sciences Group Inc (SLS) Stock Return on Shareholders’ Capital? - SETE News
SELLAS Life Sciences Group (NASDAQ:SLS) Stock Price Down 0.8% - MarketBeat
Acute Myeloid Leukemia Market Trends, Key Drivers, Opportunities, Leading Players And Forecast To 2033 - WhaTech
Biotech Soars On Material Transfer Agreement - Invezz
TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail
Lombard Odier Asset Management Europe Ltd Sells 15,000 Shares of StoneCo Ltd. (NASDAQ:STNE) - Defense World
Seelos Therapeutics surges on deal with U.S. Army to develop PTSD drug - XM
Steniel Manufacturing board clears share offering to raise up to P315m - manilastandard.net
How did SELLAS Life Sciences Group Inc (SLS) fare last session? - US Post News
SLM price target lowered to $26 from $29 at Wedbush - TipRanks
Setna iO announces new UK headquarters - AviTrader
Inspire Investing LLC Boosts Stake in Silicon Laboratories Inc. (NASDAQ:SLAB) - Defense World
Australia's Stelar Metals rises on copper, silver find - XM
Quarterly Metrics: Quick and Current Ratios for SELLAS Life Sciences Group Inc (SLS) - The Dwinnex
Investor’s Delight: ENDRA Life Sciences Inc (NDRA) Closes Weak at 0.20, Down -6.77 - The Dwinnex
Ready to Jump After Recent Trade: SELLAS Life Sciences Group Inc (SLS) - SETE News
Oman India Investment Fund sells shares worth Rs 75 cr in Senco Gold - The Economic Times
Latest News | Oman India Investment Fund Sells Shares Worth Rs 75 Cr in Senco Gold - LatestLY
Major Stake Changes in Senco Gold: Oman-India Fund Sells, ICICI Prudential Buys - Devdiscourse
Plenham Limited statement: Jason Moseley - Bodyshop Magazine
Sensiva Health names Ben Williamson as Chief Executive Officer - WV News
MASLD Associated with Greater Risk of Serious Bacterial Infection Requiring Hospitalization - MD Magazine
Barrow Hanley Mewhinney & Strauss LLC Grows Position in Standex International Co. (NYSE:SXI) - Defense World
Leonoil Completes Major Stake Acquisition of Sierra Rutile - TipRanks
Benjamin Edwards Inc. Buys 169 Shares of Standex International Co. (NYSE:SXI) - Defense World
2,100 Shares in Silicon Laboratories Inc. (NASDAQ:SLAB) Bought by MQS Management LLC - Defense World
(SMTI) Investment Report - Stock Traders Daily
Victory Capital Management Inc. Purchases 150 Shares of Silicon Laboratories Inc. (NASDAQ:SLAB) - Defense World
Avalon Global Asset Management LLC Raises Holdings in Silicon Laboratories Inc. (NASDAQ:SLAB) - MarketBeat
Granite Investment Partners LLC Increases Stock Holdings in Silicon Laboratories Inc. (NASDAQ:SLAB) - Defense World
Seneca Foods stock soars to 52-week high, hits $64 mark - Investing.com
Sylvania Director Buys Shares, Signals Confidence - TipRanks
American Century Companies Inc. Acquires 72,138 Shares of Silicon Laboratories Inc. (NASDAQ:SLAB) - Defense World
Sellas Life Sciences Group Inc (NASDAQ:SLS): A Bull Case Theory - Yahoo Finance
Sellas Life Sciences Group Inc Stock (SLS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.89%
2.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):